EDBI-backed biotech firm Moderna Therapeutics files for $500m IPO

EDBI-backed biotech firm Moderna Therapeutics files for $500m IPO

An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S., on Wednesday, Feb. 8, 2012. Photographer: David Paul Morris/Bloomberg

US biotech giant Moderna Therapeutics – which is backed by Singapore-based EDBI and Sequoia Capital China – has filed with the SEC to raise up to $500 million in an initial public offering, according to IPO investment manager Renaissance Capital.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter